Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998
Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012
Guillain-Barre Syndrome
BMJ 337:227-231, Winer,J.B., 2008
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998
Cytomegalovirus Infection and Guillain-Barre Syndrome:The Clinical, Electrophysiologic, and Prognostic Features
Neurol 47:668-673, Visser,L.H.,et al, 1996
Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995
Serologic Evidence of Campylobacter Jejuni/coli Enteritis in Patients with Guillain-Barre Syndrome
Arch Neurol 48:1080-1082, Gruenewald,R.,et al, 1991
Clinical Signs in Severe Guillain-Barre Syndrome: Analysis of 63 Patients
J Neurol Sci 104:143-150, De Jager, A.E.J.,et al, 1991
A Prospective Study of Acute Idiopathic Neuropathy, II, Antecedent Events
JNNP 51:613-618, Winer,J.B.,et al, 1988
Cytomegalovirus Complement Fixation Antibody in Guillain-Barre Syndrome
Neurol 27:1153, Dowling,P.,et al, 1977